BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31854219)

  • 21. A prognostic 4-gene expression signature for squamous cell lung carcinoma.
    Li J; Wang J; Chen Y; Yang L; Chen S
    J Cell Physiol; 2017 Dec; 232(12):3702-3713. PubMed ID: 28160492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations.
    Geng H; Li S; Guo Y; Yan F; Han Y; Xu M; Cui Y
    Cancer Biomark; 2020; 27(4):525-532. PubMed ID: 32083571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferation genes in lung development associated with the prognosis of lung adenocarcinoma but not squamous cell carcinoma.
    Li P; Zhang L; Yu X; Tong R; Di X; Mao Y; Gao Y; Zhang K; Feng L; Cheng S
    Cancer Sci; 2018 Feb; 109(2):308-316. PubMed ID: 29168602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.
    Martínez-Terroba E; Behrens C; Agorreta J; Monsó E; Millares L; Felip E; Rosell R; Ramirez JL; Remirez A; Torre W; Gil-Bazo I; Idoate MA; de-Torres JP; Pio R; Wistuba II; Pajares MJ; Montuenga LM
    Thorax; 2019 Apr; 74(4):371-379. PubMed ID: 30472670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
    Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
    Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression-based, consistent biomarkers for prognosis and diagnosis in lung cancer.
    Arroyo M; Larrosa R; Gómez-Maldonado J; Cobo MÁ; Claros MG; Bautista R
    Clin Transl Oncol; 2020 Oct; 22(10):1867-1874. PubMed ID: 32180209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
    Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
    Tang Y; Jiang Y; Qing C; Wang J; Zeng Z
    Aging (Albany NY); 2020 Dec; 13(1):794-812. PubMed ID: 33340396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and validation of an immune-associated signature in lung adenocarcinoma.
    Wang Z; Chen X
    Int Immunopharmacol; 2020 Nov; 88():106867. PubMed ID: 32799112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.
    He SY; Xi WJ; Wang X; Xu CH; Cheng L; Liu SY; Meng QQ; Li B; Wang Y; Shi HB; Wang HJ; Wang ZZ
    Med Sci Monit; 2019 May; 25():3941-3956. PubMed ID: 31132294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eight-gene signature predicts recurrence in lung adenocarcinoma.
    Zhang Y; Fan Q; Guo Y; Zhu K
    Cancer Biomark; 2020; 28(4):447-457. PubMed ID: 32508318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Molecular Mechanisms Analysis of Three Lung Cancer Subtypes Based on Gene Expression Profiles.
    Wang L; Pei Y; Li S; Zhang S; Yang Y
    J Comput Biol; 2019 Oct; 26(10):1140-1155. PubMed ID: 31305128
    [No Abstract]   [Full Text] [Related]  

  • 33. RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma.
    Wang C; Tan S; Liu WR; Lei Q; Qiao W; Wu Y; Liu X; Cheng W; Wei YQ; Peng Y; Li W
    Mol Cancer; 2019 Sep; 18(1):134. PubMed ID: 31484581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.
    Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M
    Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Subtype-Specific Prognostic Genes for Early-Stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients Using an Embedded Feature Selection Algorithm.
    Tian S
    PLoS One; 2015; 10(7):e0134630. PubMed ID: 26226392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
    Dong M; Yang Z; Li X; Zhang Z; Yin A
    Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
    Okabe N; Ezaki J; Yamaura T; Muto S; Osugi J; Tamura H; Imai J; Ito E; Yanagisawa Y; Honma R; Gotoh M; Watanabe S; Waguri S; Suzuki H
    Int J Oncol; 2015 Mar; 46(3):999-1006. PubMed ID: 25586059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
    Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
    J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling.
    Lu C; Chen H; Shan Z; Yang L
    Mol Med Rep; 2016 Aug; 14(2):1483-90. PubMed ID: 27356570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism-related genes.
    Pio R; Agorreta J; Montuenga LM
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):986-92.e1-11. PubMed ID: 26162308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.